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ABSTRACT
PURPOSE: To investigate the subcutaneous injection of carbon dioxide (CO2) on neuropeptides Calcitonin Gene-Related Peptide 
(CGRP) and Substance P (SP) secretion in rat skin.
METHODS: Fifty-six Wistar-EPM rats were distributed in two groups: one for CGRP analysis, the other for SP analysis. Each group 
was subdivided into four subgroups: control (Cont), control with needle (ContNd), CO2 injection (CO2Inj) and atmospheric air injection 
(AirInj) – with seven animals each. Sample analyses of partial skin were conducted by Western Blotting (WB). 
RESULTS: In SP group, there was a decrease in the amount of neuropeptides in subgroups CO2Inj and AirInj. Similarly, in CGRP 
group, there was a decrease in the amount of pro-CGRP neuropeptides (15 kDa) in subgroups CO2Inj and AirInj; Nevertheless, there 
was no decrease in the amount of CGRP (5 kDa) in any subgroups. 
CONCLUSION: Subcutaneous injection of CO2 and atmospheric air decreased the amount of Substance P and pro-Calcitonin Gene-
Related Peptide (15 kDa) neuropeptides in rat skin.
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Introduction
Carboxytherapy is a technique originated in 1930 in 
which carbon dioxide (CO2) is injected through a needle into 
the subcutaneous tissue. It is estimated that it increases tissue 
circulation and oxygenation. Lesions caused by the gas trigger 
a local inflammatory process which results in tissue healing, 
represented by angiogenesis and fibrogenesis. These effects 
may occur due to an increase in capillary blood flow triggered 
by hypercapnia, by a decreased consumption of cutaneous 
oxygen or by a rightward shift of the oxygen (O2) dissociation 
curve (Bohr effect)1. It is known that intranasal CO2 may inhibit 
trigeminal neuronal activation (in rats) and suppress in vitro 
calcitonin gene-related peptide (CGRP) release2. Based on this 
assumption, the efficiency of intranasal noninhaled CO2 was 
investigated in the treatment of seasonal allergic rhinitis (SAR)3. 
Although the mechanism involved in the therapeutic effect 
of CO2 on allergic rhinitis has not been examined, previous 
reports2 associate the administration of CO2 in buffered media 
to both neuronal and CGRP release inhibition, probably due 
to the inhibition of calcium channels activities and subsequent 
increase in intracellular calcium. Activation of trigeminal 
nerves was related to SAR pathogenesis, followed by mast cell 
activation and release of inflammatory mediators. Activation 
of trigeminal nerves also causes local release of neuropeptides, 
including CGRP4..
The concept of neurogenic inflammation lies in 
the fact that, when a nociceptive stimulus moves towards 
medullary processing, there is also an antidromic axon reflex 
to the A and C fibers nerve endings with consequent release of 
pro-inflammatory neuropeptides, such as CGRP, SP, neurokinin 
A (NKA), Vasoactive Intestinal Peptide (VIP), among others. 
Then, due to a cascading effect, there is inflammatory 
activation, vasodilation, chemoreceptors activation, chemotaxis 
of inflammatory cells, like neutrophils, lymphocytes, mast 
cells, keratinocytes, fibroblasts and melanocytes, and release 
of several factors such as histamine, TNF-α, prostaglandins, 
leukotrienes and interleukins5,6. The clinical manifestation 
consists of pruritus and a characteristic erythema at the site of 
the stimulus, promoting a fast start of the tissue inflammation 
process7,8. Thereby, neurogenic inflammation is the first event 
on the inflammatory phase of the healing process.
CO2 injection technique is currently used in healthcare; 
however, there are still knowledge gaps in its mode of action, 
especially in the neurogenic inflammation phase. Despite constant 
dissemination of the carboxytherapy technique and enough 
evidence for CO2 application in scars and cellulite, to date there 
is no literature with the recommended international scientific 
rigor9. Since no studies were found which correlate cutaneous 
neuropeptide concentration, specifically SP and CGRP, after 
CO2 subcutaneous injection, the objective of this study was 
to investigate the action of carboxytherapy on SP and CGRP 
neuropeptide secretion in rat skin. 
Methods
Research approved by the Ethic Committee of Sao Paulo 
Federal University [CEP 1695/10].
Fifty-six adult (eight weeks old) male Wistar-EPM 
(Rattus norvegicus) rats weighing 250-350g were used. All 
animals were housed in individual plastic cages with metal 
cover to place the container for water and commercial feed, 
consumed ad libitum. The environment was kept under 
constant temperature (22±1ºC), humidity and 12:12 hour light-
dark cycle, and the animals had one week for adaptation before 
experimental manipulation.
The animals were weighted and randomly distributed 
(www.randomization.com) into four subgroups of seven 
rats for each neuropeptide type, a total of 28 animals to 
quantify CGRP (15 kDa pro-CGRP and 5 kDa CGRP) and 
28 to SP. All the animals were submitted to trichotomy, with 
a 1 hour wait before conducting the procedures The animals 
were distributed into the following subgroups: Subgroup 1 
Control (Cont), no needle perforation; Subgroup 2 - Control 
with Needle (ContNd), with hypodermic needle perforation; 
Subgroup 3 – CO2 Injection (CO2Inj), with carbon dioxide 
injection; Subgroup 4 - Atmospheric Air Injection (AirInj), 
with atmospheric air injection.
After trichotomy, two points (A1 and A2) were marked 
in each animal using a dermographic pen, representing a line 
segment “A” located in the dorsal midline, 2 cm below the 
transverse line at the lower angle of the scapula. The needle 
puncturing for gas injection was on the central point marked at 
1.5 cm from the dorsal midline, halfway down the line segment 
A1 – A2 (Figure 1).
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The injections were subcutaneous, with 80 ml/min flow 
for 10 seconds, with a total volume of 8 ml, using a 30 G 0.30 x 4 
mm hypodermic needle, halfway down the line segment A, with a 
90-degree angle (Figure 2). 
For sample exeresis, all animals were submitted to 
painless assisted death by anesthetic overdose (five times the 
posology dose), followed by section of the great cervical vessels.
In Subgroup 1, the partial skin sample was removed 
60 minutes after hair removal (waiting time for animals from 
all subgroups to conduct experimental procedures). However, in 
Subgroups 2, 3 and 4, besides the 60-minute interval after hair 
removal to begin experimental procedures, skin samples were 
removed 21 minutes after the end of experimental procedures 
for CGRP quantification and 14 minutes for SP quantification, 
following results of a previous pilot study.
Circular incisions were made on the skin of all animals 
until the epidermis and the superficial dermis were marked using 
a 4-mm-diameter punch. An electrical dermatome (Padgett®) 
was then used to remove rectangular partial skin samples. A 
distance of at least 1 cm was maintained from the margins 
surrounding the area marked with the punch for a constant 
thickness of 500 μm – the samples’ size and shape were then 
standardized (Figures 3 to 5).
FIGURE 1 – Determining the gas injection point. Marking line segment 
A through A1 and A2 points. Rat’s back hair shaved (scapulae in yellow). 
A1 and A2 points (red) marked with dermographic pen throughout a 3-cm 
A line (not marked with pen).
FIGURE 2 – Skin expansion. Animal skin expanded by the injected CO2 
and Atmospheric air gases.
FIGURE 3 – Electrical dermatome. Animal’s back presentation and total 
skin removal with electrical dermatome. In the middle, the 4-mm area 
marked by the punch (arrow).
FIGURE 4 – Partial skin removed. After skin removal for analysis, with 
the circle marked by the 4-mm surgical punch.
Animals were submitted to general anesthesia via 
intramuscular injection of xylazine hydrochloride (50 mg/kg) 
and ketamine (100 mg/kg) at the ratio of 1:2 injected (1 ml/kg) 
into the right gastrocnemius muscle. After anesthetic induction, 
animals were placed in the prone position and their back hair was 
removed with an electric hair trimmer (WAHL®). 
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Samples collected were immediately placed in dry 
Eppendorf tubes with previously sorted random numbers. These 
tubes were frozen with dry ice and stored in freezer at -20ºC until 
the Western blotting analysis (Figure 5).
(0.2 mol/L) and SDS (0.1 %); the proteins were separated by 
applying 100 V for 1 hour and 30 minutes.
After running the gel, the proteins were transferred to 
polyvinylidene fluoride (PVDF) membrane (Bio-Rad) using a 
cold transfer buffer with trisma (25 mmol/L), glycine (0.2 mol/L) 
and methanol (10 %) for 1 hour at 100 V.
The membrane was incubated with blocking solution for 
the free sites for 15 minutes at room temperature. The blocking 
solution is composed by 0.05 % milk in tris-buffered saline with 
Tween-20 (TBS-T). After blocking, the membranes were incubated 
with primary antibodies: anti-Substance P polyclonal antibody 
produced in goats (1/100, Santa Cruz) and anti-CGRP polyclonal 
antibody produced in rabbits (1/300, Sigma), both diluted in milk 
(3%) in TBS-T for 24 hours at 4ºC and constant stirring. After 
this incubation, the membranes were washed twice for 10 minutes 
in TBS-T and incubated with the secondary antibodies, anti-goat 
and anti-rabbit (1/2.000, GE and 1/10.000, GE, respectively), 
conjugated to a peroxidase (HRP-conjugated), diluted in milk 
(3%) in TBS-T and incubated for 1 hour at room temperature.
After incubation with the secondary antibodies, the 
membranes were washed twice in TBS-T and once in tris-
buffered saline (TBS) for 10 minutes each. The reaction 
occurred by incubation with chemiluminescent reagent 
(Western Lightning Chemiluminescence Reagent Plus, ECL kit, 
Perkinelmer, USA) for exactly 1 minute. The membranes were 
exposed to a chemiluminescent-sensitive film (Hyperfilm ECL, 
Amersham Biosciences) for 30 seconds to 5 minutes, depending 
on the antibody, and developed according to the manufacturer’s 
instructions.
After development of films, the membranes were washed 
and submitted to new labeling with antibody to beta-actin in 
order to normalize protein values. To do so, the membranes 
were incubated with primary antibody against beta-actin diluted 
at 1:30.000 (Sigma, USA) in TBS-T with 1% Bovine Serum 
Albumin (BSA) for 1 hour at room temperature, then washed 
twice for 10 minutes with TBS-T and incubated for 45 minutes 
at room temperature with the secondary antibody (anti-rabbit, 
HRP-conjugated, Amersham) diluted at 1:10.000 in TBS-T with 
1% BSA. After these incubations, the membranes were washed 
as previously described, which was followed by reaction and film 
developing11. The films were quantified by optical densitometry 
using an image analyzing system, as described by Chadi et al.11..
SP and CGRP quantification in skin samples were 
obtained in arbitrary units presented as average, standard 
deviation, and maximum and minimum values. The Kolmogorov-
Smirnov Test was performed to assess the normality of data. When 
Protein extraction by Western blotting
Fragments collected from each animal were homogenized 
in buffered solution for total protein extraction. First, the fragments 
were lysed and homogenized with a homogenizer using 350 µL 
of lysis buffer consisting of NP40 (1 %), sodium deoxycholate 
(0.5 %), sodium dodecylsulphate (SDS, 1 %), edetic acid (EDTA, 
1 mmol/L), egtazic acid (EGTA, 1 mmol/L) and protease-inhibitor 
cocktail (Sigma, 1 %) in PBS (pH 7.4). After homogenization, 
the tubes were centrifuged at 14,000 rpm for 20 minutes at 4 
ºC. Supernatants were obtained and the amount of protein was 
determined according to the Bradford method [10].
Samples were diluted in lysis buffer to obtain 60 µg in 
25 µL of buffer. They were then denatured at 100 ºC for 3 minutes 
and applied to the 12 % polyacrylamide gel wells for separation. 
Five µL of molecular weight marker were applied to one of the 
small wells (Kaleidoscope, pre-colored, Bio-Rad, USA). The 
running buffer was prepared with trisma (25 mmol/L), glycine 
FIGURA 5 – A. Standardized skin sample. Skin sample removed from 
the middle of line A (after punch) resulting in a 500-μm thick circular 
shaped partial skin fragment for analysis (kept in an Eppendorf tube to 
send to Western blotting analysis). B. Photomicrography (x10) of HE-
stained samples showing constant thickness.
A
B
Raymundo EC et al.
228 - Acta Cirúrgica Brasileira - Vol. 29 (4) 2014
non-normality of data was detected, Wilcoxon Mann Whitney 
intragroup test was performed. For all tests, a p-value of .05 was 
considered significant (SPSS software).
Results
Regarding 15 kDa CGRP secretion, neuropeptide 
quantification in Control Subgroup (Cont) did not differ from 
Control with Needle Subgroup (ContNd) (Figure 6). The same 
happened for the subgroups in which CO2 and atmospheric air were 
injected. On the other hand, a difference was observed (p=0.025 
and p=0.009, respectively) between the control subgroups versus 
CO2 and atmospheric air subgroups Still analyzing the graph, an 
outlier was noted at the sample, which was considered, as it didn’t 
affect the study’s result. There was no difference (p>0.05) in the 5 
kDa CGRP quantification among subgroups (Figure 7).
The graph concerning SP neuropeptide quantification 
showed similar behavior and same hypothesis as the ones described 
for 15 kDa CGRP Group (Figure 8). Neuropeptide quantification 
in Control Subgroup (Cont) did not differ from Control with 
Needle Subgroup (ContNd). The same happened for subgroups 
receiving CO2 or Atmospheric Air Injection. A significant 
difference (p=0.013 and 0.003, respectively) occurred between 
control versus CO2 or Atmospheric Air Injection subgroups. Also, 
an outlier was noted at the sample, which was considered as it 
didn’t affect the study’s result.
FIGURE 7 – 5 kDa CGRP neuropeptide quantification by Western 
blotting. Subgroups: Cont = Control; ContNd = Control with Needle; 
CO2Inj = CO2 Injection; AirInj = Atmospheric Air Injection.
FIGURE 6 – 15 kDa CGRP neuropeptide quantification by Western 
blotting. Subgroups: Cont = Control; ContNd = Control with Needle; 
CO2Inj = CO2 Injection; AirInj = Atmospheric Air Injection.
FIGURE 8 – SP neuropeptide quantification by Western blotting. 
Subgroups: Cont = Control; ContNd = Control with Needle; CO2Inj = 
CO2 Injection; AirInj = Atmospheric Air Injection.
After the first analyses, the Kolmogorov Smirnov Test 
has been applied to the three groups: 15 kDa CGRP (p=0.976), 5 
kDa CGRP (p=0.907) and SP (p=0.848) and none of the samples 
presented normality, according to the p-values.
The Wilcoxon Mann Whitney Test was then applied, 
which compared subgroups two by two.
Regarding the 15 kDa CGRP sample, the only subgroups 
that did not present a significant difference in neuropeptide 
quantification were CO2Inj compared to AirInj (p=0.749). Cont 
and ContNd subgroups showed a difference in neuropeptide 
quantification when compared to the other subgroups.
The next tested sample was 5 kDa CGRP, which did 
not present statistically significant difference in neuropeptide 
quantification in any of the subgroups.
To conclude the analyses, the SP sample was tested, 
which did not present any difference in neuropeptide quantification 
between Cont and ContNd subgroups (p=0.949), and in the 
comparison between CO2Inj and AirInj (p=0.949).
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Discussion
There is arteriolar vasodilation with formation of a papule 
and erythema in neurogenic inflammation. Any damage or stimulus 
to the skin may trigger neurogenic inflammation. Exudation of 
plasma and neurogenic vasodilation may be inhibited by blocking 
the nerve impulse and its conduction, mast cell stabilization, 
blocking capsaicin receptors, blocking ionic channels, with use 
of anti-inflammatory steroids, depletion of neurotransmitters and 
pre-synaptic inhibition12.
Due to the importance of CGRP and SP neuropeptides 
in the skin, this study aimed at investigating the influence of 
carbon dioxide (CO2) on the release of these neuropeptides, which 
helps clarify the mechanisms leading to the increase in vascular 
perfusion by CO2. 
Neuropeptides are easily released by nerve endings, and 
their availability standard in skin and cell internalization are not 
studied enough13,14. Therefore, the process of hair removal could 
be a decisive factor of cutaneous neuropeptide release, since the 
removal of hair by any method also implies microtraumas on the 
animal’s skin. 
Since there are no studies in the literature determining the 
degradation time of neuropeptides in the interstitium of the skin, a 
pilot study was necessary to determine how long these substances 
take to return to physiological concentrations in the skin after hair 
removal. SP and CGRP return to basal values in up to 60 minutes 
after the generation of a single stimulus. A 60-minute time was 
thus established for the beginning of the experiment after hair 
removal, when concentrations of both neuropeptides had already 
been undoubtedly in physiological levels. Neither Drucker et 
al.15 nor Rajkovic et al.16 claimed waiting for any period of time 
after hair removal, which could represent a bias in neuropeptide 
quantification in the skin. 
Regarding gas injection, another pilot study was 
necessary (non-published data) to determine the time for detecting 
SP and CGRP neuropeptides in rat skin after CO2 and Atmospheric 
air injection. Accordingly, to determine the moment of sacrificing 
and removal of partial skin, a specific waiting time was established 
for each neuropeptide group: 14 minutes for SP and 21 for CGRP. 
For CO2 application, this study used the subcutaneous 
injection technique because according to a previous study, 
this technique promoted greater cutaneous distension and less 
resistance to needle puncturing than the intradermal application 
technique. This corroborates the findings of Ferreira et al.17, which 
emphasize the need for research to compare intradermal and 
subcutaneous injections, as well as to define the volume of gas 
used and the frequency of treatment sessions. In this study, a 80 
ml/min flow for 10 seconds was standardized, in a single point and 
using a hypodermic needle at 90 degrees from the skin.
The experimental model used the rat’s dorsal region, 
which is 900 to 1.000 µm thick and has abundant hair follicle 
above 500 µm deep. According to Rajkovic et al.16 nerve endings 
are concentrated on the epidermis and on the upper half of the 
dermis and the hair follicles. For being richly endowed with 
nerves and abundant in neuropeptides, they can mask the analysis 
of subtler events on the skin surface. Thus, this study used an 
electrical dermatome so that the partial skin would have a constant 
thickness (500 µm) and that there was no difference in volume 
among samples, or that they would not inadvertently come with 
subcutaneous tissue or panniculus carnosus.
Dorsal root ganglia neuronal cell bodies synthesize 
CGRP by the transcription of calcitonin/CGRP gene, where a 
15 kDa precursor molecule called pro-CGRP is synthesized in 
the endoplasmic reticulum and processed in the Golgi apparatus. 
Pro-CGRP is transported antidromically down the axon to the free 
cutaneous endings, then cleaved into CGRP (active form), with 
approximately 5 kDa, and released in the interstitium upon a local 
stimulus. Mishima et al.18 investigated the influence of CGRP in 
ischemic limbs revascularization in rats and quantified pro-CGRP 
to prove the release and increase in CGRP production during the 
experiment. This study demonstrated a total depletion of pro-
CGRP levels in skin, which suggests cleavage of this precursor 
and CGRP release in the skin.
Neurogenic inflammation is involved in physiological 
and pathological processes of wound healing; therefore, the 
possibility of modulating its initial stages – delaying, inhibiting 
or stimulating it – would bring the perspective of controlling these 
processes, eventually optimizing the time required for normal 
wound healing and correcting pathological wound healing. The 
results of this study show that carbon dioxide injections promote 
a decrease in the amount of pro-CGRP and SP neuropeptides, 
corroborating the findings of Vause et al.2 who observed that 
CO2 can inhibit CGRP release by trigeminal neurons. Also, and 
surprisingly, subcutaneous injection of atmospheric air, which 
also decreases the amount of neuropeptides, open perspectives 
for researches with air injection as to modulate neuropeptides and 
thus neurogenic inflammation in the skin. In this context, the use 
of the carbon dioxide injection technique could be beneficial as 
an adjunct therapy by modulating the secretion of neuropeptides, 
controlling cutaneous diseases of neuropeptidergic source, such 
as psoriasis, atopic dermatitis and keloid, besides the classical 
treatment. In conclusion, carbon dioxide and atmospheric air 
Raymundo EC et al.
230 - Acta Cirúrgica Brasileira - Vol. 29 (4) 2014
injections in rat skin caused a local decrease in the amount of 
Substance P and pro-Calcitonin Gene-Related Peptide (pro-
CGRP) neuropeptides.
Conclusion
Subcutaneous injection of CO2 and atmospheric air 
decreased the amount of Substance P and pro-Calcitonin Gene-
Related Peptide (15 kDa) neuropeptides in rat skin.
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